Perelman School of Medicine

‘Alarming’ diabetes epidemic in Guatemala tied to aging, not obesity

A new study by Penn Center for Global Health, published in PLOS One, finds that 25 percent of the large indigenous population in Guatemala has either type 2 diabetes or pre-diabetes.

Penn Medicine’s Carl June receives 2018 Albany Prize

Carl June, a gene therapy pioneer at the Abramson Cancer Center, will receive the 2018 Albany Medical Center Prize in Medicine and Biomedical Research.

Two students’ paths to White Coat Day

Ralph St. Luce & Rotem Kimia, two members of a new class of medical students at the Perelman School of Medicine, discuss what brought them to medicine, in anticipation of the school's annual White Coat Ceremony.

In cells under duress, stress granules (in magenta) form outside of the nucleus (in blue). TDP-43 protein in green (arrow) that cannot bind to PolyADP ribose (PAR) builds up in large clumps distinct from stress granules. (Image: Leeanne McGurk, University of Pennsylvania; Molecular Cell)

Drugs in development for cancer may also fight brain diseases, including ALS

In a study done by researchers at the Perelman School of Medicine and the School of Arts and Sciences, PARP inhibitors, which are used for fighting cancer, can be useful for the treatment and prevention of brain disorders such as ALS.

Cancer cells send out ‘drones’ to battle the immune system from afar

Checkpoint inhibitor therapies have made metastatic melanoma and other cancers a survivable condition, but only for some patients. Researchers uncovered a novel mechanism by which tumors suppress the immune system, raising the possibility that a straightforward blood test could predict which patients could respond to immunotherapy.

Ensuring equality with a framework for workforce inclusion

A study published in JAMA Network Open from researchers at the Perelman School of Medicine identifies six factors that measure workforce inequality in delivering health care, as part of Office of Inclusion and Diversity’s equality mission.

Red blood cell “hitchhikers” offer new way to transport drugs to specific targets

A new drug-delivery technology which uses red blood cells to shuttle nano-scale drug carriers, called RBC-hitchhiking, has been found to dramatically increase the concentration of drugs ferried precisely to selected organs.

Dr. Benoit Dubé appointed Chief Wellness Officer

Provost Wendell Pritchett and Vice Provost for University Life Valarie Swain-Cade McCoullum today announced the appointment of Dr. Benoit Dubé, Associate Professor of Clinical Psychiatry, as the University of Pennsylvania’s first Chief Wellness Officer.

Criminologist John MacDonald and emergency medicine physician Eugenia South of the University of Pennsylvania.

Greening vacant lots reduces depression in city dwellers

People living within a quarter mile of greened lots had a 41.5 percent decrease in feelings of depression and a nearly 63 percent decrease in self-reported “poor mental health,” compared to those who lived near the lots that received no intervention.

The changing landscape of mosquito- and tick-borne diseases

Lyme disease, West Nile virus, Zika, chikungunya, and dengue are among the vector-borne infections making headlines. Penn researchers shed light on what’s behind the spread and how to stay safe.

Filters